Changing the Game in
Drug Development and Patient Access

Model-informed Drug Development
Health Economics/Outcomes Research & Real World Evidence
Regulatory Science, Strategy & Services

Certara Launches Version 8.1 of Industry-leading Phoenix PK/PD M&S Software; Introduces Professional Certification Program

Certara Acquires Analytica Laser, a Leader in Market Access, HEOR, and Real-world Evidence Solutions

Certara Acquires BaseCase, a Life Sciences Data Visualization Company

FDA Renews and Expands its Portfolio of Simcyp Simulator Licenses

Increased Use of PBPK Modeling and Simulation is a Priority in Both the Prescription Drug User Fee Act and Generic Drug User Fee Amendments

Our Mission

Enable superior drug development and patient care decision-making through model-informed drug development, regulatory science, real world evidence and knowledge integration, thus optimizing R&D productivity, commercial value and patient outcomes.

Latest from Certara

Blog

In the Press

Webinars